0001127602-12-013035.txt : 20120403 0001127602-12-013035.hdr.sgml : 20120403 20120403175829 ACCESSION NUMBER: 0001127602-12-013035 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20120326 FILED AS OF DATE: 20120403 DATE AS OF CHANGE: 20120403 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: CLACKSON TIMOTHY P CENTRAL INDEX KEY: 0001242992 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-21696 FILM NUMBER: 12739266 MAIL ADDRESS: STREET 1: C/O ARIAD PHARMACEUTICALS INC STREET 2: 26 LANDSDOWNE STREET CITY: CAMBRIDGE STATE: MA ZIP: 02139 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: ARIAD PHARMACEUTICALS INC CENTRAL INDEX KEY: 0000884731 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 223106987 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 26 LANDSDOWNE ST CITY: CAMBRIDGE STATE: MA ZIP: 02139 BUSINESS PHONE: 6174940400 MAIL ADDRESS: STREET 1: 26 LANDSDOWNE CITY: CAMBRIDGE STATE: MA ZIP: 02139 4 1 form4.xml PRIMARY DOCUMENT X0305 4 2012-03-26 0000884731 ARIAD PHARMACEUTICALS INC ARIA 0001242992 CLACKSON TIMOTHY P C/O ARIAD PHARMACEUTICALS INC 26 LANDSDOWNE STREET CAMBRIDGE MA 02139 1 President, R&D, CSO Common Stock 2012-03-26 4 S 0 26061 16.3415 D 264689 D Common Stock 2012-04-01 4 M 0 13000 0 A 277689 D Common Stock 2012-04-03 4 S 0 5200 16.1796 D 272489 D Restricted Stock Units 2012-04-01 4 M 0 13000 0 D Common Stock 13000 26000 D This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 22, 2011. Shares were acquired upon vesting of restricted stock units awarded on April 1, 2011. Represents shares sold to satisfy withholding tax requirements. Shares were sold pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 22, 2011. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $16.06 to $16.31, inclusive. The reporting person undertakes to provide to ARIAD Pharmaceuticals, Inc. ("ARIAD"), any security holder of ARIAD, or the staff of the Security and Exchange Commission, upon request, full information regarding the shares sold at each separate price within the range set forth in this footnote. Each restricted stock unit represents a right to receive one share of ARIAD common stock. Restricted stock units awarded on April 1, 2011 vest as to 33-1/3% of the award on each of April 1, 2012, April 1, 2013, and April 1, 2014. /s/Edward M. Fitzgerald, Attorney-in-Fact 2012-04-03